Mitsubishi UFJ Asset Management Co. Ltd. Purchases 18,679 Shares of Axon Enterprise, Inc $AXON

Key Points

• Mitsubishi UFJ Asset Management increased its stake in Axon by 11.9%, buying 18,679 shares to hold 176,208 shares (about 0.22% of the company) worth roughly $99.3 million.
• Axon posted a Q1 revenue beat of ~$807 million (+34% Y/Y), raised its 2026 revenue growth guidance to 30–32%, and said AI and counter‑drone businesses are surging (AI revenue up ~700% Y/Y), signaling new high‑growth drivers beyond TASER and cameras.
• Analysts remain largely bullish (16 Buys, consensus target ~$722.69), but the stock carries a stretched valuation (P/E ~171) despite a recent price uptick of about 10%, which could temper investor sentiment.

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 11.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 176,208 shares of the biotechnology company's stock after acquiring an additional 18,679 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.22% of Axon Enterprise worth $99,284,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Stone House Investment Management LLC bought a new stake in Axon Enterprise in the 3rd quarter valued at about $29,000. New Millennium Group LLC bought a new stake in Axon Enterprise in the 3rd quarter valued at about $29,000. Sound Income Strategies LLC raised its stake in Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company's stock valued at $30,000 after acquiring an additional 44 shares during the period. Camelot Portfolios LLC bought a new stake in Axon Enterprise in the 4th quarter valued at about $30,000. Finally, Root Financial Partners LLC bought a new stake in Axon Enterprise in the 3rd quarter valued at about $34,000. 79.08% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on AXON shares. William Blair restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. Citigroup reiterated a "buy" rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Robert W. Baird set a $800.00 price target on Axon Enterprise in a research report on Wednesday, February 25th. Morgan Stanley set a $600.00 price target on Axon Enterprise in a research report on Thursday. Finally, The Goldman Sachs Group set a $535.00 price target on Axon Enterprise in a research report on Thursday. Sixteen investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $722.69.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Company raised 2026 revenue growth guidance to 30%–32% and is targeting about $450M in free cash flow, signaling stronger cash conversion and confidence in demand. Axon raises 2026 revenue growth outlook to 30%-32% while targeting about
• Positive Sentiment: AI and counter‑drone businesses surged: AI product revenue reported up ~700% Y/Y and counter‑drone bookings/revenue rose several hundred percent, providing a new, high‑growth revenue stream beyond Taser and cameras. Axon Raises Guidance With AI Revenue Up 700%
• Positive Sentiment: Q1 revenue beat: revenue of ~$807M (+34% Y/Y) and strong bookings/ARR commentary underpin the company’s claim of durable growth across software, devices and international markets. Axon reports Q1 2026 revenue of $807 million, up 34% year over year
• Positive Sentiment: Analyst bullishness: JPMorgan raised its price target and kept an overweight stance, reflecting confidence from at least one major sell‑side shop. Benzinga: JPMorgan raises PT to $755
• Neutral Sentiment: Some brokers maintained Buy ratings and high targets (Needham, William Blair), signalling continued conviction but no consensus on valuation. Axon Maintained at Buy as Strong Growth Outlook Supports Unchanged $600 Price Target
• Neutral Sentiment: Media pieces are debating valuation — analysts’ average recommendations skew optimistic, so investors should weigh runway (AI/counter‑drone) against a stretched multiple. Is Axon (AXON) a Buy as Wall Street Analysts Look Optimistic?
• Negative Sentiment: EPS/margin noise: some reports flagged an EPS miss or tariff‑driven margin pressure despite revenue strength, which tempers the beat and raises near‑term margin visibility concerns. AXON Q1 Earnings Miss Estimates on Tariff-Driven Margins
• Negative Sentiment: Some firms trimmed price targets (Citizens/JMP, Piper Sandler lowered targets), reflecting divergent views on valuation and risk — a potential headwind for sentiment. Citizens Jmp lowers PT (TickerReport) Piper Sandler lowers PT (TickerReport)
• Negative Sentiment: Market reaction was mixed—some coverage notes shares slipped at times despite the beat, showing investors are parsing margins, guidance details and valuation. Axon Shares Slip Despite Q1 Results Above Expectations

Axon Enterprise Stock Up 10.6%

Shares of NASDAQ AXON opened at $426.89 on Friday. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $34.39 billion, a price-to-earnings ratio of 171.44, a PEG ratio of 8.24 and a beta of 1.44. The business has a 50-day moving average of $451.93 and a 200-day moving average of $527.52.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.95% and a net margin of 6.90%.The company had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.91 million. During the same quarter in the previous year, the firm earned $1.47 earnings per share. Axon Enterprise's revenue was up 33.7% on a year-over-year basis. Sell-side analysts expect that Axon Enterprise, Inc will post 1.41 earnings per share for the current fiscal year.

Insider Activity at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the transaction, the chief executive officer owned 3,090,997 shares of the company's stock, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeri Williams sold 157 shares of the business's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total value of $76,930.00. Following the transaction, the director directly owned 1,159 shares of the company's stock, valued at $567,910. The trade was a 11.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 13,855 shares of company stock valued at $7,109,828 in the last ninety days. Insiders own 4.40% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.